HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Activation of glucose-6-phosphate dehydrogenase promotes acute hypoxic pulmonary artery contraction.

Abstract
Hypoxic pulmonary vasoconstriction (HPV) is a physiological response to a decrease in airway O(2) tension, but the underlying mechanism is incompletely understood. We studied the contribution of glucose-6-phosphate dehydrogenase (Glc-6-PD), an important regulator of NADPH redox and production of reactive oxygen species, to the development of HPV. We found that hypoxia (95% N(2), 5% CO(2)) increased contraction of bovine pulmonary artery (PA) precontracted with KCl or serotonin. Depletion of extracellular glucose reduced NADPH, NADH, and HPV, substantiating the idea that glucose metabolism and Glc-6-PD play roles in the response of PA to hypoxia. Our data also show that inhibition of glycolysis and mitochondrial respiration (indicated by an increase in NAD(+) and decrease in the ATP-to-ADP ratio) by hypoxia, or by inhibitors of pyruvate dehydrogenase or electron transport chain complexes I or III, increased generation of reactive oxygen species, which in turn activated Glc-6-PD. Inhibition of Glc-6-PD decreased Ca(2+) sensitivity to the myofilaments and diminished Ca(2+)-independent and -dependent myosin light chain phosphorylation otherwise increased by hypoxia. Silencing Glc-6-PD expression in PA using a targeted small interfering RNA abolished HPV and decreased extracellular Ca(2+)-dependent PA contraction increased by hypoxia. Similarly, Glc-6-PD expression and activity were significantly reduced in lungs from Glc-6-PD(mut(-/-)) mice, and there was a corresponding reduction in HPV. Finally, regression analysis relating Glc-6-PD activity and the NADPH-to-NADP(+) ratio to the HPV response clearly indicated a positive linear relationship between Glc-6-PD activity and HPV. Based on these findings, we propose that Glc-6-PD and NADPH redox are crucially involved in the mechanism of HPV and, in turn, may play a key role in increasing pulmonary arterial pressure, which is involved in the development of pulmonary hypertension.
AuthorsRakhee S Gupte, Dhawjbahadur K Rawat, Sukrutha Chettimada, Donna L Cioffi, Michael S Wolin, William T Gerthoffer, Ivan F McMurtry, Sachin A Gupte
JournalThe Journal of biological chemistry (J Biol Chem) Vol. 285 Issue 25 Pg. 19561-71 (Jun 18 2010) ISSN: 1083-351X [Electronic] United States
PMID20363753 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • NADP
  • Glucosephosphate Dehydrogenase
  • Glucose
  • Calcium
Topics
  • Animals
  • Blood Pressure
  • Calcium (metabolism)
  • Cattle
  • Enzyme Activation
  • Glucose (metabolism)
  • Glucosephosphate Dehydrogenase (metabolism)
  • Hypoxia
  • Lung (pathology)
  • NADP (metabolism)
  • Oxidation-Reduction
  • Phosphorylation
  • Pulmonary Artery (enzymology)
  • Vasoconstriction

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: